高级检索
中华皮肤科杂志
期刊首页
过刊列表
高级检索
稿件发表
• 指南与共识 •
ENGLISH ABSTRACT
中国卡波西肉瘤诊疗专家共识（2023版）
中国医师协会皮肤科医师分会
中国研究型医院学会皮肤科学专业委员会
作者及单位信息
·
DOI： 10.35541/cjd.20230261
Consensus on the diagnosis and treatment of Kaposi's sarcoma in China (2023)
China Dermatologist Association;
Dermatology Professional Committee of Chinese Research Hospital Society
Kang Xiaojing
Wang Gang
Authors Info & Affiliations
China Dermatologist Association;
Dermatology Professional Committee of Chinese Research Hospital Society
Kang Xiaojing
Wang Gang
·
DOI： 10.35541/cjd.20230261
1699
479
0
0
13
1
PDF下载
APP内阅读
摘要

卡波西肉瘤是一种内皮细胞起源的多中心性肉瘤，好发于皮肤，可累及黏膜、淋巴结和内脏器官。卡波西肉瘤发病与人类疱疹病毒8型感染、免疫、环境及遗传等因素相关，且近年来发病呈现增长趋势。中国医师协会皮肤科医师分会及中国研究型医院学会皮肤科学专业委员会组织相关专家在复习国内外文献及诊疗指南的基础上，结合我国的诊疗现状，制订了中国卡波西肉瘤诊疗专家共识，旨在为临床医生规范化诊疗提供参考。

肉瘤，卡波西;治疗;诊断;专家共识
ABSTRACT

Kaposi's sarcoma is a multicentric sarcoma of endothelial cell origin, which mainly occurs on the skin and can involve the mucosa, lymph nodes and internal organs. The occurrence of Kaposi's sarcoma is associated with human herpesvirus 8 infection, immunity, environment, genetics, and other factors. The incidence of Kaposi's sarcoma has shown an increasing trend in recent years. The China Dermatologist Association and Dermatology Professional Committee of Chinese Research Hospital Society organized relevant experts to develop an expert consensus on the diagnosis and treatment of Kaposi's sarcoma in China based on a review of Chinese and international literature including guidelines and combined with the current status of its diagnosis and treatment in China, aiming to provide a reference for clinicians to standardize its diagnosis and treatment.

Sarcoma, Kaposi;Therapy;Diagnosis;Consensus statement
Kang Xiaojing, Email: mocdef.3ab61666jxgnakrd;
Wang Gang, Email: nc.defudabe.ummfgnagwjx
Copyright by Chinese Medical Association
No content published by the journals of Chinese Medical Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission.
All articles published represent the opinions of the authors, and do not reflect the official policy of the Chinese Medical Association or the Editorial Board, unless this is clearly specified.
引用本文

中国医师协会皮肤科医师分会,中国研究型医院学会皮肤科学专业委员会. 中国卡波西肉瘤诊疗专家共识（2023版）[J]. 中华皮肤科杂志,2023,56(10)：899-906.

DOI:10.35541/cjd.20230261

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价

版权归中华医学会所有。

未经授权，不得转载、摘编本刊文章，不得使用本刊的版式设计。

除非特别声明，本刊刊出的所有文章不代表中华医学会和本刊编委会的观点。

卡波西肉瘤（Kaposi's sarcoma，KS）又名多发性特发性出血性肉瘤，是一种内皮细胞源性的多中心性肿瘤，1872年Moritz Kaposi首次报道。KS临床常分为4型：经典型、艾滋病相关型（流行型）、医源性（免疫抑制型）和非洲地方型 [ 1 ]。2018年法国研究者将人类免疫缺陷病毒（HIV）阴性男男性行为KS定义为第五种类型 [ 2 ]，但是在欧洲KS诊疗指南及美国国家综合癌症网络指南中均未进行分类，国内也无报道。2022年我国估计新增KS患者282例，死亡171例 [ 3 ]。近年来KS发病机制研究及诊疗手段取得较大进展，但我国尚无KS的诊疗指南或共识。为提高我国KS的诊疗水平，规范临床诊治，特制订KS诊疗专家共识。
试读结束，您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Cesarman E , Damania B , Krown SE ,et al. Kaposi sarcoma[J]. Nat Rev Dis Primers, 2019,5（1）:9. doi: 10.1038/s41572-019-0060-9 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Denis D , Seta V , Regnier-Rosencher E ,et al. A fifth subtype of Kaposi′s sarcoma, classic Kaposi′s sarcoma in men who have sex with men: a cohort study in Paris[J]. J Eur Acad Dermatol Venereol, 2018,32（8）:1377-1384. doi: 10.1111/jdv.14831 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
Xia C , Dong X , Li H ,et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J （Engl）, 2022,135（5）:584-590. doi: 10.1097/CM9.0000000000002108 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
Mulder RL , Brown MC , Skinner R ,et al. Handbook for guideline development[DB/OL]. International Guideline Harmonization Group, PanCareSurFup and Cochrane Childhood Cancer Group, 2014（2014-09）[2023-01-01]. http://www.ighg.org/wp-content/uploads/2013/10/Handbook-for-guideline-development_Version-1_September-2014.pdf.
返回引文位置Google Scholar
百度学术
万方数据
[5]
陈耀龙,杨克虎,王小钦,等. 中国制订/修订临床诊疗指南的指导原则（2022版）[J]. 中华医学杂志, 2022,102（10）:697-703. doi: 10.3760/cma.j.cn112137-20211228-02911 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
刘海波,刘芳,桑红. 在皮肤学科指南中应用GRADE证据质量分级和推荐强度评价系统的意义[J]. 中华皮肤科杂志, 2018,51（9）:639-641. doi: 10.3760/cma.j.issn.0412-4030.2018.09.001 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Atkins D , Best D , Briss PA ,et al. Grading quality of evidence and strength of recommendations[J]. BMJ, 2004,328（7454）:1490. doi: 10.1136/bmj.328.7454.1490 .
返回引文位置Google Scholar
百度学术
万方数据
[8]
中华医学会杂志社指南与标准研究中心,中国医学科学院循证评价与指南研究创新单元,世界卫生组织指南实施与知识转化合作中心. 2021年医学期刊发表中国指南和共识的科学性、透明性和适用性的评级[J]. 中华医学杂志, 2022,102（30）:2320-2329. doi: 10.3760/cma.j.cn112137-20220602-01232 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
National Comprehensive Cancer Network. Kaposi Sarcoma, version 1, 2023[DB/OL]. National Comprehensive Cancer Network, 2023. [ 2023-02-01]. https://www.nccn.org/professionals/physician_gls/pdf/kaposi.pdf.
返回引文位置Google Scholar
百度学术
万方数据
[10]
Lebbe C , Garbe C , Stratigos AJ ,et al. Diagnosis and treatment of Kaposi′s sarcoma: European consensus-based interdisciplinary guideline（EDF/EADO/EORTC）[J]. Eur J Cancer, 2019,114:117-127. doi: 10.1016/j.ejca.2018.12.036 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Grulich AE , Beral V , Swerdlow AJ . Kaposi′s sarcoma in England and Wales before the AIDS epidemic[J]. Br J Cancer, 1992,66（6）:1135-1137. doi: 10.1038/bjc.1992.423 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Cottoni F , De Marco R , Montesu MA . Classical Kaposi′s sarcoma in north-east Sardinia: an overview from 1977 to 1991[J]. Br J Cancer, 1996,73（9）:1132-1133. doi: 10.1038/bjc.1996.217 .
返回引文位置Google Scholar
百度学术
万方数据
[13]
Hjalgrim H , Melbye M , Pukkala E ,et al. Epidemiology of Kaposi′s sarcoma in the Nordic countries before the AIDS epidemic[J]. Br J Cancer, 1996,74（9）:1499-1502. doi: 10.1038/bjc.1996.572 .
返回引文位置Google Scholar
百度学术
万方数据
[14]
Wu XJ , Pu XM , Kang XJ ,et al. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China[J]. J Eur Acad Dermatol Venereol, 2014,28（11）:1545-1552. doi: 10.1111/jdv.12349 .
返回引文位置Google Scholar
百度学术
万方数据
[15]
Beral V , Peterman TA , Berkelman RL ,et al. Kaposi′s sarcoma among persons with AIDS: a sexually transmitted infection?[J]. Lancet, 1990,335（8682）:123-128. doi: 10.1016/0140-6736(90)90001-l .
返回引文位置Google Scholar
百度学术
万方数据
[16]
Hernández-Ramírez RU , Shiels MS , Dubrow R ,et al. Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study[J]. Lancet HIV, 2017,4（11）:e495-e504. doi: 10.1016/S2352-3018(17)30125-X .
返回引文位置Google Scholar
百度学术
万方数据
[17]
Yarchoan R , Uldrick TS . HIV-associated cancers and related diseases[J]. N Engl J Med, 2018,378（11）:1029-1041. doi: 10.1056/NEJMra1615896 .
返回引文位置Google Scholar
百度学术
万方数据
[18]
Bejar C , Basset-Seguin N , Faure F ,et al. French ENT Society （SFORL）guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous origin[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2014,131（2）:121-129. doi: 10.1016/j.anorl.2014.02.002 .
返回引文位置Google Scholar
百度学术
万方数据
[19]
Lebbé C , Legendre C , Francès C . Kaposi sarcoma in transplantation[J]. Transplant Rev（Orlando）, 2008,22（4）:252-261. doi: 10.1016/j.trre.2008.05.004 .
返回引文位置Google Scholar
百度学术
万方数据
[20]
Antman K , Chang Y . Kaposi′s sarcoma[J]. N Engl J Med, 2000,342（14）:1027-1038. doi: 10.1056/NEJM200004063421407 .
返回引文位置Google Scholar
百度学术
万方数据
[21]
Hiatt KM , Nelson AM , Lichy JH ,et al. Classic Kaposi sarcoma in the United States over the last two decades: a clinicopathologic and molecular study of 438 non-HIV-related Kaposi sarcoma patients with comparison to HIV-related Kaposi sarcoma[J]. Mod Pathol, 2008,21（5）:572-582. doi: 10.1038/modpathol.2008.15 .
返回引文位置Google Scholar
百度学术
万方数据
[22]
康晓静,沈大为,普雄明,等. 新疆KaPosi肉瘤组织内人类8型疱疹病毒DNA的检测[J]. 中华皮肤科杂志, 2001,34（6）:417-419. doi: 10.3760/j.issn:0412-4030.2001.06.001 .
返回引文位置Google Scholar
百度学术
万方数据
[23]
Hellert J , Weidner-Glunde M , Krausze J ,et al. The 3D structure of Kaposi sarcoma herpesvirus LANA C-terminal domain bound to DNA[J]. Proc Natl Acad Sci U S A, 2015,112（21）:6694-6699. doi: 10.1073/pnas.1421804112 .
返回引文位置Google Scholar
百度学术
万方数据
[24]
Judde JG , Lacoste V , Brière J ,et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi′s sarcoma and other diseases[J]. J Natl Cancer Inst, 2000,92（9）:729-736. doi: 10.1093/jnci/92.9.729 .
返回引文位置Google Scholar
百度学术
万方数据
[25]
赵辨. 中国临床皮肤病学[M]. 南京:江苏科学技术出版社, 2010.
返回引文位置
[26]
James WD , Berger TG , Elston DM . 安德鲁斯临床皮肤病学[M]. 徐世正主译. 10版. 北京:科学出版社, 2008.
返回引文位置
[27]
Tambussi G , Repetto L , Torri V ,et al. Epidemic HIV-related Kaposi′s sarcoma: a retrospective analysis and validation of TIS staging. GICAT. Gruppo Italiano Collaborativo AIDS e Tumori[J]. Ann Oncol, 1995,6（4）:383-387. doi: 10.1093/oxfordjournals.annonc.a059188 .
返回引文位置Google Scholar
百度学术
万方数据
[28]
Krown SE , Metroka C , Wernz JC . Kaposi′s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee[J]. J Clin Oncol, 1989,7（9）:1201-1207. doi: 10.1200/JCO.1989.7.9.1201 .
返回引文位置Google Scholar
百度学术
万方数据
[29]
Brambilla L , Genovese G , Berti E ,et al. Diagnosis and treatment of classic and iatrogenic Kaposi′s sarcoma: Italian recommendations[J]. Ital J Dermatol Venerol, 2021,156（3）:356-365. doi: 10.23736/S2784-8671.20.06703-6 .
返回引文位置Google Scholar
百度学术
万方数据
[30]
Htet KZ , Waul MA , Leslie KS . Topical treatments for Kaposi sarcoma: a systematic review[J]. Skin Health Dis, 2022,2（2）:e107. doi: 10.1002/ski2.107 .
返回引文位置Google Scholar
百度学术
万方数据
[31]
Célestin Schartz NE , Chevret S , Paz C ,et al. Imiquimod 5% cream for treatment of HIV-negative Kaposi′s sarcoma skin lesions: a phase Ⅰ to Ⅱ, open-label trial in 17 patients[J]. J Am Acad Dermatol, 2008,58（4）:585-591. doi: 10.1016/j.jaad.2007.11.005 .
返回引文位置Google Scholar
百度学术
万方数据
[32]
Abdelmaksoud A , Filoni A , Giudice G ,et al. Classic and HIV-related Kaposi sarcoma treated with 0.1% topical timolol gel[J]. J Am Acad Dermatol, 2017,76（1）:153-155. doi: 10.1016/j.jaad.2016.08.041 .
返回引文位置Google Scholar
百度学术
万方数据
[33]
Bodsworth NJ , Bloch M , Bower M ,et al. Phase Ⅲ vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi′s sarcoma[J]. Am J Clin Dermatol, 2001,2（2）:77-87. doi: 10.2165/00128071-200102020-00004 .
返回引文位置Google Scholar
百度学术
万方数据
[34]
Epstein JB . Treatment of oral Kaposi sarcoma with intralesional vinblastine[J]. Cancer, 1993,71（5）:1722-1725. doi: 10.1002/1097-0142(19930301)71:5<1722::aid-cncr2820710503>3.0.co;2-0 .
返回引文位置Google Scholar
百度学术
万方数据
[35]
Régnier-Rosencher E , Guillot B , Dupin N . Treatments for classic Kaposi sarcoma: a systematic review of the literature[J]. J Am Acad Dermatol, 2013,68（2）:313-331. doi: 10.1016/j.jaad.2012.04.018 .
返回引文位置Google Scholar
百度学术
万方数据
[36]
Trattner A , Reizis Z , David M ,et al. The therapeutic effect of intralesional interferon in classical Kaposi′s sarcoma[J]. Br J Dermatol, 1993,129（5）:590-593. doi: 10.1111/j.1365-2133.1993.tb00490.x .
返回引文位置Google Scholar
百度学术
万方数据
[37]
Chun YS , Chang SN , Park WH . A case of classical Kaposi′s sarcoma of the penis showing a good response to high-energy pulsed carbon dioxide laser therapy[J]. J Dermatol, 1999,26（4）:240-243. doi: 10.1111/j.1346-8138.1999.tb03464.x .
返回引文位置Google Scholar
百度学术
万方数据
[38]
Odyakmaz Demirsoy E , Bayramgürler D , Çağlayan Ç ,et al. Imiquimod 5% cream versus cryotherapy in classic Kaposi sarcoma[J]. J Cutan Med Surg, 2019,23（5）:488-495. doi: 10.1177/1203475419847954 .
返回引文位置Google Scholar
百度学术
万方数据
[39]
Di Monta G , Caracò C , Benedetto L ,et al. Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi′s sarcoma[J]. Eur J Surg Oncol, 2014,40（1）:61-66. doi: 10.1016/j.ejso.2013.09.002 .
返回引文位置Google Scholar
百度学术
万方数据
[40]
Latini A , Bonadies A , Trento E ,et al. Effective treatment of Kaposi′s sarcoma by electrochemotherapy and intravenous bleomycin administration[J]. Dermatol Ther, 2012,25（2）:214-218. doi: 10.1111/j.1529-8019.2012.01437.x .
返回引文位置Google Scholar
百度学术
万方数据
[41]
Simonart T . What is the role of surgery in the treatment of Kaposi′s sarcoma?[J]. J Eur Acad Dermatol Venereol, 2007,21（4）:573. doi: 10.1111/j.1468-3083.2006.01971.x .
返回引文位置Google Scholar
百度学术
万方数据
[42]
Tsao MN , Sinclair E , Assaad D ,et al. Radiation therapy for the treatment of skin Kaposi sarcoma[J]. Ann Palliat Med, 2016,5（4）:298-302. doi: 10.21037/apm.2016.08.03 .
返回引文位置Google Scholar
百度学术
万方数据
[43]
Singh NB , Lakier RH , Donde B . Hypofractionated radiation therapy in the treatment of epidemic Kaposi sarcoma--a prospective randomized trial[J]. Radiother Oncol, 2008,88（2）:211-216. doi: 10.1016/j.radonc.2008.03.009 .
返回引文位置Google Scholar
百度学术
万方数据
[44]
Kirova YM , Belembaogo E , Frikha H ,et al. Radiotherapy in the management of epidemic Kaposi′s sarcoma: a retrospective study of 643 cases[J]. Radiother Oncol, 1998,46（1）:19-22. doi: 10.1016/s0167-8140(97)00147-3 .
返回引文位置Google Scholar
百度学术
万方数据
[45]
Hauerstock D , Gerstein W , Vuong T . Results of radiation therapy for treatment of classic Kaposi sarcoma[J]. J Cutan Med Surg, 2009,13（1）:18-21. doi: 10.2310/7750.2008.07076 .
返回引文位置Google Scholar
百度学术
万方数据
[46]
Northfelt DW , Dezube BJ , Thommes JA ,et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi′s sarcoma: results of a randomized phase Ⅲ clinical trial[J]. J Clin Oncol, 1998,16（7）:2445-2451. doi: 10.1200/JCO.1998.16.7.2445 .
返回引文位置Google Scholar
百度学术
万方数据
[47]
Armenian SH , Lacchetti C , Barac A ,et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: american society of clinical oncology clinical practice guideline[J]. J Clin Oncol, 2017,35（8）:893-911. doi: 10.1200/JCO.2016.70.5400 .
返回引文位置Google Scholar
百度学术
万方数据
[48]
D′Amico F , Fuxman C , Nachman F ,et al. Visceral Kaposi′s sarcoma remission after intestinal transplant. First case report and systematic literature review[J]. Transplantation, 2010,90（5）:547-554. doi: 10.1097/TP.0b013e3181ea3936 .
返回引文位置Google Scholar
百度学术
万方数据
[49]
Cianfrocca M , Lee S , Von Roenn J ,et al. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy[J]. Cancer, 2010,116（16）:3969-3977. doi: 10.1002/cncr.25362 .
返回引文位置Google Scholar
百度学术
万方数据
[50]
Tourlaki A , Germiniasi F , Rossi LC ,et al. Paclitaxel as first- or second-line treatment for HIV-negative Kaposi′s sarcoma: a retrospective study of 58 patients[J]. J Dermatolog Treat, 2020,31（2）:183-185. doi: 10.1080/09546634.2019.1590520 .
返回引文位置Google Scholar
百度学术
万方数据
[51]
Stallone G , Schena A , Infante B ,et al. Sirolimus for Kaposi′s sarcoma in renal-transplant recipients[J]. N Engl J Med, 2005,352（13）:1317-1323. doi: 10.1056/NEJMoa042831 .
返回引文位置Google Scholar
百度学术
万方数据
[52]
Tur E , Brenner S . Classic Kaposi′s sarcoma: low-dose interferon alfa treatment[J]. Dermatology, 1998,197（1）:37-42. doi: 10.1159/000017973 .
返回引文位置Google Scholar
百度学术
万方数据
[53]
屈园园,王鹏,李婷婷,等. 新疆地区64例卡波西肉瘤的临床特征与治疗分析[J]. 中国皮肤性病学杂志, 2021,35（12）:1365-1370. doi: 10.1089/107999002753675712
返回引文位置Google Scholar
百度学术
万方数据
[54]
Krown SE , Li P , Von Roenn JH ,et al. Efficacy of low-dose interferon with antiretroviral therapy in Kaposi′s sarcoma: a randomized phase Ⅱ AIDS clinical trials group study[J]. J Interferon Cytokine Res, 2002,22（3）:295-303. doi: 10.1089/107999002753675712 .
返回引文位置Google Scholar
百度学术
万方数据
[55]
Rokx C , van der Ende ME , Verbon A ,et al. Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients[J]. Clin Infect Dis, 2013,57（10）:1497-1499. doi: 10.1093/cid/cit517 .
返回引文位置Google Scholar
百度学术
万方数据
[56]
Polizzotto MN , Uldrick TS , Wyvill KM ,et al. Pomalidomide for symptomatic Kaposi′s sarcoma in people with and without HIV infection: a phase Ⅰ/Ⅱ study[J]. J Clin Oncol, 2016,34（34）:4125-4131. doi: 10.1200/JCO.2016.69.3812 .
返回引文位置Google Scholar
百度学术
万方数据
[57]
中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南（2021年版）[J]. 中国艾滋病性病, 2021,27（11）:1182-1201. doi: 10.12290/xhyxzz.2022-0097 .
返回引文位置Google Scholar
百度学术
万方数据
[58]
Costa da Cunha CS , Lebbe C , Rybojad M ,et al. Long-term follow-up of non-HIV Kaposi′s sarcoma treated with low-dose recombinant interferon alfa-2b[J]. Arch Dermatol, 1996,132（3）:285-290. doi: 10.1001/archderm.132.3.285 .
返回引文位置Google Scholar
百度学术
万方数据
[59]
Robey RC , Bower M . Facing up to the ongoing challenge of Kaposi′s sarcoma[J]. Curr Opin Infect Dis, 2015,28（1）:31-40. doi: 10.1097/QCO.0000000000000122 .
返回引文位置Google Scholar
百度学术
万方数据
[60]
Therasse P , Arbuck SG , Eisenhauer EA ,et al. New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada[J]. J Natl Cancer Inst, 2000,92（3）:205-216. doi: 10.1093/jnci/92.3.205 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
康晓静，Email： mocdef.3ab61666jxgnakrd；
B
王刚，Email： nc.defudabe.ummfgnagwjx
C
所有作者均声明无利益冲突
评论 （0条）
注册
登录
时间排序
暂无评论，发表第一条评论抢沙发
最新推荐
更多
中国银屑病诊疗指南（2023版）
中华医学会皮肤性病学分会银屑病专业委员会
中华皮肤科杂志 2023,56(07)
中国毛霉病临床诊疗专家共识（2022）
中国医药教育协会真菌病专业委员会 等
中华内科杂志 2023,62(06)
成人皮肌炎诊疗中国专家共识（2022年）
中国医疗保健国际交流促进会皮肤科分会 等
中华皮肤科杂志 2022,55(11)
中国带状疱疹诊疗专家共识（2022版）
中国医师协会皮肤科医师分会带状疱疹专家共识工作组 等
中华皮肤科杂志 2022,55(12)
MedAI助手（体验版）
文档即答
智问智答
机器翻译
回答内容由人工智能生成，我社无法保证其准确性和完整性，该生成内容不代表我们的态度或观点，仅供参考。
生成快照
文献快照

你好，我可以帮助您更好的了解本文，请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持：

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号
小中大